Most small pharmas, and most companies in general, just do quarterly updates, if that, and only press release when they have something relatively important to share. I've actually grown a whole lot more wary of companies pumping out PR after PR.

And I could be wrong but I doubt management's current interactions with investors are mediated by the legal dept.

I do hope they will answer a good bit of questions in the upcoming call and would like to ask about the possibility of government funding for Dr Sacha's open ended viral suppression MOA. Seems like something governments around the world may be interested in funding.